Molecular basis for dimer formation of TRbeta variant D355R.
Proteins
; 75(1): 111-7, 2009 Apr.
Article
em En
| MEDLINE
| ID: mdl-18798561
ABSTRACT
Protein quality and stability are critical during protein purification for X-ray crystallography. A target protein that is easy to manipulate and crystallize becomes a valuable product useful for high-throughput crystallography for drug design and discovery. In this work, a single surface mutation, D355R, was shown to be crucial for converting the modestly stable monomeric ligand binding domain of the human thyroid hormone receptor (TR LBD) into a stable dimer. The structure of D335R TR LBD mutant was solved using X-ray crystallography and refined to 2.2 A resolution with R(free)/R values of 24.5/21.7. The crystal asymmetric unit reveals the TR dimer with two molecules of the hormone-bound LBD related by twofold symmetry. The ionic interface between the two LBDs comprises residues within loop H10-H11 and loop H6-H7 as well as the C-terminal halves of helices 8 of both protomers. Direct intermolecular contacts formed between the introduced residue Arg 355 of one TR molecule and Glu 324 of the second molecule become a part of the extended dimerization interface of 1330 A(2) characteristic for a strong complex assembly that is additionally strengthened by buffer solutes.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Receptores dos Hormônios Tireóideos
/
Proteínas Mutantes
Idioma:
En
Ano de publicação:
2009
Tipo de documento:
Article